GL1X · GenesisL1 explorer

MolNFT v1 · #80047 · protein

Discovery of gdc-0980: a potent, selective, and orally available class I phosphatidylinositol 3-kinase (PI3K)/MAMMALIAN target of rapamycin (mtor) kinase inhibitor for the treatment of cancer

3TL5: “Discovery of gdc-0980: a potent, selective, and orally available class I phosphatidylinositol 3-kinase…”. X-ray diffraction. MolNFT v1 #80047 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
3TL5
Type
protein
Length
845 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P48736

Structure

x-ray diffraction · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein845—P48736

Compared structures

  • 3TL5 · Discovery of GDC-0980: a Potent, Selective, and Orally Available Class I… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.